TECNOTREE
19.9.2022 11:01:39 CEST | Business Wire | Press release
Tecnotree, a leading global Digital Transformation Partner for the Telecom Industry, is the first non-telco to be certified for real-world open API implementation on the leader board for TM Forum Open API Conformance. The certifications were carried out jointly with MTN in live operations within the MTN environment and demonstrated the successful implementation of Open APIs in commercial products and real-world deployments. Alignment to industry standards and best practices have been a part of Tecnotree’s DNA and its Digital Transformation strategy and proves Tecnotree’s commitment to industry standards, customers, and partner ecosystems. This landmark achievement makes Tecnotree the first Digital Platform Company among a list of CSPs like Verizon, Bell, and JIO, for certified real-world open API implementation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220919005054/en/
Tecnotree is the First Digital Platform Company in the World to be Certified for Real-World Open API Implementation by TM Forum (Photo: Business Wire)
Tecnotree’s Digital Platform powered with Open APIs using Open Digital Architecture enables quick and flexible integration to transform telecom business and operation models that extends beyond connectivity to monetise platform-based business models and partner ecosystems across verticals.
“We congratulate Tecnotree for being the first non-telco to achieve real-world certification for Open APIs deployed in live operation with MTN,” commented George Glass, CTO of TM Forum. “This is a path-breaking move by a software solutions provider and reaffirms Tecnotree’s commitment to open standards and their investment in next-generation product modernization. Tecnotree has been a great supporter of TM Forum’s work and is demonstrating the business value of Open APIs in enabling digital transformation for their customers.”
Monzer Ali, CTIO of MTN Uganda commented, “MTN and Tecnotree have been at the forefront of aligning with TM Forum frameworks (TAM, SID, Open APIs, eTOM) in our digital transformation journey. Tecnotree Digital BSS Suite is TMF ODA’s component-based architecture and is fully cloud-enabled, having an orchestration of micro-services capability that allows us to provide not only connectivity services for our subscribers but also digital services from adjacent industries, thus truly helping us monetize the power of 5G.”
Padma Ravichander, CEO of Tecnotree Corporation said, “This recognition is a true testimony of our journey as a pioneer in TM Forum’s Open API certification. Real-world Open API conformance and certification for Tecnotree is our commitment towards our customers to help them unlock and monetize the power of 5G with a range of digital products and services. These solutions can be provided to their customers, with seamless connectivity, speed, agility, and interoperability, on our Tecnotree Digital BSS platform. Our platform further enables operators to partner with the industry’s best ecosystem players to monetize B2B and B2B2X non-telco offerings by leveraging 5G for new digital multi-experiences.”
TM Forum Open API suite was developed in collaboration to drive IT agility, and digital business transformation. The certification recognizes how well your industry solutions, business processes, or open APIs align within the industry standards. They unlock a range of growth opportunities by providing exposure to new products and services while reducing cost and time to market. A large number of major global operators and vendors use the TM Forum Open API conformance, and the APIs are deployed all over the world.
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree is the first company in the world to be Platinum Certified by TM Forum Open API standards, and our agile and open-source Digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree digital platform products and services today serve over 1 Billion Subscribers globally in over 70 countries. Tecnotree is listed on Helsinki Nasdaq (TEM1V).
For more information, please visit www.tecnotree.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220919005054/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom